Interleukin-1 Inhibitors: Uses, Benefits, and Side Effects

Introduction: Key Points About Interleukin-1 Inhibitors

Interleukin-1 inhibitors are a class of medications designed to treat inflammatory conditions by blocking the effects of interleukin-1 (IL-1), a protein that triggers inflammation in the body. These medications are often prescribed for conditions such as rheumatoid arthritis, certain autoinflammatory diseases, and psoriasis. By reducing inflammation, they help alleviate symptoms like pain, swelling, and stiffness. If you have an inflammatory condition, your healthcare provider may suggest this class of drugs as part of your treatment plan.

Medications in the Interleukin-1 Inhibitors Class

Common medications within the interleukin-1 inhibitors class include:

1. Arcalyst (rilonacept)
2. Kineret (anakinra)
3. Ilumya (tildrakizumab)
4. Taltz (ixekizumab)

The generic name, listed in parentheses, refers to the non-branded version of the medication. It contains the same active ingredient as the brand-name drug but may be marketed under different names.

How Do IL-1 Inhibitors Work? Mechanism of Action

Interleukin-1 inhibitors work by blocking the activity of interleukin-1 (IL-1), a protein that plays a crucial role in the body’s inflammatory response. IL-1 is part of the immune system’s defense mechanism against injury or infection. However, in some individuals, IL-1 can cause excessive inflammation, leading to chronic conditions like rheumatoid arthritis or autoinflammatory diseases. By inhibiting IL-1, these medications help reduce inflammation and manage symptoms.

Different medications in this class may target IL-1 in slightly different ways. For example, Kineret (anakinra) binds directly to the IL-1 receptor, preventing IL-1 from activating it. On the other hand, Arcalyst (rilonacept) acts as a “decoy receptor,” capturing IL-1 before it can bind to its natural receptor. Despite these variations, all medications in this class aim to reduce inflammation by disrupting IL-1 signaling.

Benefits of Interleukin-1 Inhibitors

Interleukin-1 inhibitors are used to treat a range of inflammatory conditions, including rheumatoid arthritis, systemic juvenile idiopathic arthritis (SJIA), and rare autoinflammatory diseases such as cryopyrin-associated periodic syndromes (CAPS). These medications are often considered when other treatments, like nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids, are ineffective or cause undesirable side effects.

One of the key advantages of IL-1 inhibitors is their ability to specifically target the inflammatory process, leading to improved symptom control with fewer side effects compared to broader immunosuppressive therapies. If you’re experiencing symptoms of an inflammatory condition, consult with one of our healthcare providers through telemedicine to determine if an IL-1 inhibitor might be suitable for you.

Potential Side Effects of Interleukin-1 Inhibitors

Like all medications, interleukin-1 inhibitors can cause side effects. It’s important to be aware of these potential reactions and discuss any concerns with your healthcare provider before starting treatment. Below, we outline the most common side effects, followed by less frequent ones. If you experience any severe side effects, contact your doctor immediately. You can also schedule a telemedicine appointment with one of our providers for prompt assistance.

Common Side Effects (≥1%)

1. Injection site reactions (up to 40%): The most common side effect, which may include redness, swelling, or pain at the injection site. These reactions are typically mild and resolve within a few days.
2. Upper respiratory tract infections (up to 12%): Symptoms may include a runny nose, sore throat, or cough. Patients with a history of frequent infections may be at a higher risk.
3. Headache (up to 12%): Some patients report mild to moderate headaches while taking interleukin-1 inhibitors. These headaches are usually manageable with over-the-counter pain relievers.
4. Nausea (up to 7%): Nausea can occur, particularly when starting the medication. Eating small, frequent meals may help ease this symptom.
5. Diarrhea (up to 5%): Some patients may experience loose stools or diarrhea. Staying hydrated and avoiding fatty or spicy foods can help manage this side effect.
6. Fatigue (up to 4%): Feeling unusually tired or fatigued is another reported side effect. If fatigue becomes severe or persistent, consult your healthcare provider.

Less Common Side Effects (<1%)

These side effects are rare but have been reported in some patients:

1. Fever
2. Dizziness
3. Muscle pain
4. Joint pain
5. Rash
6. Weight gain
7. Abnormal liver function tests
8. Low white blood cell count
9. Increased risk of serious infections

Severe Side Effects

Although rare, some patients may experience severe side effects. These include:

1. Serious infections: Interleukin-1 inhibitors can weaken your immune system, making it easier to develop serious infections such as pneumonia or tuberculosis. If you have a history of recurrent infections or are at higher risk (e.g., due to advanced age or chronic illness), your doctor may monitor you closely.
2. Allergic reactions: In rare cases, patients may experience severe allergic reactions, including difficulty breathing, swelling of the face or throat, or hives. If you notice any of these symptoms, seek emergency medical attention immediately.
3. Neutropenia: A significant reduction in white blood cells, which can increase the risk of infections. Your doctor may monitor your blood counts regularly to ensure your immune system remains healthy.

If you experience any of these severe side effects, stop taking the medication and contact your healthcare provider right away. You can also schedule a telemedicine appointment with one of our providers for immediate guidance.

Drug to Drug Interactions

Interleukin-1 inhibitors, also known as IL-1 inhibitors, can interact with other medications, potentially affecting their efficacy or increasing the likelihood of side effects. It’s crucial to inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements. Some notable drug interactions include:

TNF inhibitors (e.g., etanercept, infliximab): Combining Interleukin-1 inhibitors with TNF inhibitors can significantly raise the risk of serious infections. For this reason, using these medications together is generally not recommended.

Live vaccines: Interleukin-1 inhibitors may reduce the effectiveness of live vaccines and increase the risk of infection from the vaccine itself. It is advised to avoid live vaccines while undergoing treatment with this medication.

Immunosuppressants (e.g., methotrexate, cyclosporine): Using Interleukin-1 inhibitors alongside other immunosuppressive drugs can further weaken your immune system, heightening the risk of severe infections.

Warfarin: There may be an increased risk of bleeding when Interleukin-1 inhibitors are used in combination with blood thinners like warfarin. Your doctor may need to monitor your blood clotting levels more closely to ensure your safety.

Always consult your healthcare provider before starting any new medications to prevent potential interactions. If you have concerns, our telemedicine team is available to help you review your medications and ensure your treatment plan is safe and effective.

Precautions and Contraindications

Before beginning treatment with Interleukin-1 inhibitors, it’s important to discuss your medical history with your healthcare provider. Certain conditions may increase your risk of complications or make this medication unsuitable for you. Key precautions and contraindications include:

History of infections: If you have a history of frequent or chronic infections, Interleukin-1 inhibitors may increase your susceptibility to serious infections. Your doctor may recommend closer monitoring or alternative treatment options.

Immunosuppression: Patients with weakened immune systems, whether due to other medications or underlying medical conditions, should use Interleukin-1 inhibitors with caution. Your healthcare provider will carefully assess whether the benefits of the medication outweigh the risks in your specific case.

Active infections: If you currently have an active infection, your doctor may delay starting Interleukin-1 inhibitors until the infection has been fully treated.

Pregnancy and breastfeeding: There is limited information on the safety of Interleukin-1 inhibitors during pregnancy and breastfeeding. If you are pregnant, planning to become pregnant, or breastfeeding, it’s important to discuss your treatment options with your healthcare provider.

Liver disease: Patients with liver disease may require additional monitoring while taking Interleukin-1 inhibitors, as these medications can impact liver function.

Having an open and thorough conversation with your healthcare provider about your medical history and any potential risks is essential. If you have any questions or concerns, our telemedicine providers are here to guide you through the decision-making process and help you make informed choices about your treatment.

Conclusion

Interleukin-1 inhibitors, including IL-1 receptor antagonists like Anakinra and Canakinumab, offer a valuable treatment option for individuals with inflammatory conditions such as rheumatoid arthritis and periodic fever syndromes. While these medications can provide significant relief, it’s important to be aware of potential side effects, drug interactions, and necessary precautions. Always consult your healthcare provider before starting or discontinuing any medication. If you have any questions or need personalized advice, our telemedicine team is here to support you in managing your health safely and effectively. Schedule an appointment today to discuss whether Interleukin-1 inhibitors are the right choice for you.

James Kingsley

Learn More